Effects of metformin versus sulfonylureas on atherogenic indices and cardiometabolic risk in type 2 diabetes mellitus

Endocrine and Metabolic Science · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles